Dec 8, 2022Sales leadership addition at Certis Biologicals
To meet the rising demand of biological crop protection, Certis Biologicals has named Mike Allan vice president of business development and licensing. Allan will seek opportunities for the biologicals leader to expand innovation efforts through partnerships, licensing and potential acquisitions, according to a news release.
“There is staggering investment in the agriculture space right now and biologicals are at the forefront of many of those innovation efforts,” Amy O’Shea, Certis’ president and CEO, said in the release. “With our strong commitment to science, the internal innovation possible at our laboratory facilities and our access to the market, we believe that we are a strong partner for emerging technology players. Mike’s industry breadth and respect will be key in leveraging these strengths for the overall growth of the sector.”
“Certis Biologicals has always been committed to bringing new technologies to the marketplace so that growers can feel comfortable protecting their crops and the environments in which they grow,” Allan said in the release. “We have successfully launched many of these new advancements by leveraging partnerships with external collaborators such as W. Neudorff GmbH KG, Kaken Pharmaceutical Co., LTD and Novozymes. Dedication to this effort will bring vast opportunity to our innovation pipeline and to growers around the world who need additional crop protection tools.”
Certis is a leading global manufacturer, innovator, developer and marketer of biological solutions for use in commercial agriculture, professional greenhouse and consumer markets.